Literature DB >> 14086214

TREATMENT OF MYCOBACTERIAL SKIN ULCERS IN UGANDA WITH A RIMINOPHENAZINE DERIVATIVE (B.663).

H F LUNN, R J REE.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS; MICE; MYCOBACTERIUM INFECTIONS; PHENAZINES; SKIN ULCER; UGANDA

Mesh：

Substances：

Year:  1964        PMID： 14086214     DOI： 10.1016/s0140-6736(64)92351-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

Review 2.  [Mycobacterium ulcerans infection in man (Baruli-ulcer)].

Authors:  G Kieninger; G E Schubert; U Ullmann; W Höfler
Journal:  Infection       Date:  1973       Impact factor: 3.553

3.  Experimental chemotherapy of tuberculosis.

Authors:  J Batten
Journal:  Br Med J       Date:  1968-07-13

4.  Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer.

Authors:  Paul J Converse; Deepak V Almeida; Eric L Nuermberger
Journal:  Methods Mol Biol       Date:  2022

5.  Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli Group.

Authors: 
Journal:  Br Med J       Date:  1970-05-16

Review 6.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

Review 7.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

8.  Mycobacteria and the skin.

Authors:  J M Grange
Journal:  Int J Dermatol       Date:  1982-11       Impact factor: 2.736
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.